As healthcare organizations combat the COVID-19 surge, executives need to plan for what comes next.
Our team of experts created a document to help answer questions that arose during our April 9 discussion of the CARES Act.
Learn from organizations that have already implemented robust remote teams, and align operations for a potential sustained WFH period while looking ahead and developing strategies for the future.
Five safeguards health systems can use to limit regulatory risk and avoid similar pitfalls to those alleged in recent case filings.
Immediate legislative action can position AMCs to lead the nation’s response to the pandemic.
COVID-19 will slow transactions in the short term, but opportunities exist for savvy buyers.
In this article, we highlight five common errors that are especially relevant to parties that engage valuators and rely on their opinions to demonstrate compliance with the law.
How should clinical trials continue to operate during the COVID-19 pandemic?
A guide intended for hospital leaders to prioritize work activities of their facilities staff in response to COVID-19. The high-impact and enhanced readiness actions presented in this blog will help safeguard the staff and patients within the facility.
Page 2 of 81